>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance: PTN +19.3% (thinly traded), PLPM +18% (light volume), HALO +16.4% (also Data Monitoring Committee for Study 202 of PEGPH20 now supports continued enrollment of patients), RAX +13%, TC +8.2%, GORO +8%, APRI +6.2% (also receives FDA Clearance to Begin Clinical Trial of RayVa for Secondary Raynaud's Phenomenon), WIX +6.1%, (light volume),OSIR +5.8% (light volume), RNF +5.5%, (light volume), MBI +4.4%, MCK +3.7%, NOAH +2.2%, PVA +1.9%, HEAR +1.3% (light volume), LOV +1%, AMBC +1% (light volume), ECA +0.8% (light volume), CST +0.7%.

M&A news: DTV +3.8% (ongoing AT&T (T) deal speculation; reports out indicate may be announced within two weeks and bid near $100/share), AZN +1.5% (Pfizer announces presentation: Possible offer for AstraZeneca represents compelling shareholder value; Bloomberg discusses that Pfizer may increase bid for AZN above current $84/share offer), AGN +1.4% (Valeant Pharma responds to Allergan's rejection of merger proposal; believe that offer is substantially superior to an Allergan 'go it alone' strategy).

Select miners stocks trading higher: BBL +1.6%, MT +0.8%, BHP +0.6%.

Social media related names showing strength: YELP +1.3%, SINA +0.8%, TWTR +0.6%, FB +0.5% (Facebook considering China sales office, according to reports).

Other news: GMCR +5.4% (Coca-Cola files amended SC13D disclosing increased ownership of up to 16.0% stake), CSUN +3.5% (raises Q1 total shipment guidance to be above 140MW from prior range of 130MW-140MW; reiterates Q1 gross margin to remain mid-single digit ), GSK +3.1% (China plans to brief media on probe, according to reports ), PLUG +2.6% (ahead of Wedbush conference), NBS+2% (announces licensing agreement and plans to begin Phase 2 Hepatocellular Carcinoma Trial in China; up to $30 mln of license fees could be received by the co over the life of the agreement), ALU +1.7% (still checking), WDAY +1.5% (following positive MadMoney mention), HLF +1.2% (still checking), XOXO +1.1% (Becker Drapkin confirms stake in 13D filing; intends to engage company and may nominate or recommend candidates to serve on the Board), TWTR +1.1% (still checking), WY +0.9% (announces intention to split-off Weyerhaeuser Real Estate Company), VE +0.9% (still checking), BTU +0.7% (extends Chairman and CEO employment term to implement next phase in executive succession planning process ), HOT +0.6% and MAR +0.5% (following positive MadMoney mention), CXO+0.5% (announces upsizing and pricing of 6.5 mln share common stock offering at $129.00 per share).

Analyst comments: UBNT +1.7% (upgraded to Strong Buy from Outperform at Raymond James ), BPI +1.3% ( upgraded to Hold from Sell at Deutsche Bank ), TWX +0.5% (upgraded to Outperform from Mkt Perform at Bernstein), QGEN +0.1% (upgraded to Neutral from Underweight at HSBC Securities)